Expert consensus from the Arabian Gulf on selecting disease-modifying treatment for people with multiple sclerosis according to disease activity

Raed Alroughani*, Jihad Inshasi, Abdullah Al-Asmi, Abdulradha Alqallaf, Abdulla Al Salti, Ahmed Shatila, Amir Boshra, Beatriz Canibano, Dirk Deleu, Isa Al Sharoqi, Jaber Al Khabouri

*Corresponding author for this work

Research output: Contribution to journalReview articlepeer-review

3 Citations (Scopus)


Recent research has expanded our understanding of the natural history and clinical course of multiple sclerosis (MS) in the Arabian Gulf region. In addition, the number of available therapies for MS has increased greatly in recent years, which complicates considerably the design of therapeutic regimens. We, an expert group of physicians practising in Arabian Gulf countries, present pragmatic consensus recommendations for the use of disease-modifying therapy, according to the level of MS disease activity, according to objective criteria, and prior treatment (if any) received by a given patient.

Original languageEnglish
Pages (from-to)368-376
Number of pages9
JournalPostgraduate Medicine
Issue number4
Publication statusPublished - May 18 2020


  • Multiple sclerosis
  • consensus statement
  • disease-modifying therapy

ASJC Scopus subject areas

  • Medicine(all)

Cite this